Health Optimization Index
TRT (Testosterone Replacement Therapy)
- Nick’s assessment
- Experimental
- Research evidence
- A, strong evidence
- Attention
- 11.2 / 100▼ Falling this week
BioHarmony score
TRT can be high-upside for men with documented symptomatic hypogonadism: the T Trials support sexual-function and mood benefits, while TRAVERSE lowered concern about major cardiovascular events but left AF, pulmonary embolism, blood-pressure, fertility, and dependency concerns.
Read the full report Benefits, risks and practical guidance.
Read Nick’s assessment Why it earned this rating
TRT (Testosterone Replacement Therapy) is a 5.5–6.0/10 fit for people weighing hormonal, libido, and energy, especially when the goal is a tracked experiment with clear endpoints. The strongest evidence anchor is Xu 2024: 28 RCTs, 3,461 patients; erectile-function scores improved without statistically significant intermediate-term prostate or urinary worsening. Zarrouf 2009 adds a second signal, but TRT (Testosterone Replacement Therapy) still has gaps around large trials, long-term outcomes, responder profiles, or real-world adherence. That makes TRT (Testosterone Replacement Therapy) useful for a defined reader, while weaker for broad anti-aging or catch-all wellness claims. In practice, TRT (Testosterone Replacement Therapy) belongs after basics, diagnosis when relevant, and a stop rule based on symptoms, labs, sleep, or performance.
✅ Best for: Men 35+ with documented symptomatic hypogonadism on two separate morning tests who already addressed sleep, body composition, alcohol, micronutrients, training, medications, and stress. Men with primary hypogonadism where lifestyle will not restore levels. Older hypogonadal men with sarcopenia, anemia, low bone density, low libido, or persistent depressive symptoms under careful monitoring. Men with hypogonadism plus type 2 diabetes or metabolic syndrome when TRT is prescribed for deficiency symptoms, not as glucose medicine. Competitive athletes only if medically indicated and covered by a valid WADA therapeutic-use exemption.
❌ Avoid if: You have one low or borderline testosterone result without repeat morning confirmation, fertility plans in the next 12 months without a urology plan, untreated severe sleep apnea, baseline polycythemia, thrombophilia, uncontrolled hypertension, severe heart failure, recent MI or stroke, active prostate or breast cancer, unexplained PSA rise, or a clinic that skips LH, FSH, hematocrit, estradiol-sensitive, PSA when age-appropriate, and lifestyle review. Also avoid TRT as a first move for fatigue, brain fog, low motivation, or body recomposition when sleep, training, calories, alcohol, and medications are unresolved.
Share your experience
Your answers are optional and help other readers — they never change my score. How community input works.
One step left: confirm it’s you
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.
Make a 12-month prediction Will it rise or fall in the Index?
Choose a direction and your confidence. Correct predictions earn leaderboard points.
Your prediction is final once submitted. We’ll check it in 12 months. See the leaderboard →